Mouse Anti-CLEC14A Recombinant Antibody (C8488) (V2LY-1206-LY88)

Qiao, C., Qiu, Y., Zou, Y., Hua, C., Li, Y., Jin, Y., & Lin, X. (2021). Bleomycin inhibits CLEC14A to attenuate the progression of extracranial arteriovenous malformations. Chinese Journal of Plastic and Reconstructive Surgery.

Sandoval, D. R., Toledo, A. G., Painter, C. D., Tota, E. M., Sheikh, M. O., West, A. M., ... & Esko, J. D. (2020). Proteomics-based screening of the endothelial heparan sulfate interactome reveals that C-type lectin 14a (CLEC14A) is a heparin-binding protein. Journal of Biological Chemistry, 295(9), 2804-2821.

Kim, Y., Lee, S., Zhang, H., Lee, S., Kim, H., Kim, Y., ... & Kwon, Y. G. (2020). CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation. Journal of neuroinflammation, 17(1), 1-14.

Bocci, M., Sjölund, J., Kurzejamska, E., Lindgren, D., Marzouka, N. A. D., Bartoschek, M., ... & Pietras, K. (2019). Activin receptor-like kinase 1 is associated with immune cell infiltration and regulates CLEC14A transcription in cancer. Angiogenesis, 22(1), 117-131.

Kim, T. K., Park, C. S., Jang, J., Kim, M. R., Na, H. J., Lee, K., ... & Lee, S. (2018). Inhibition of VEGF‐dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC 14a. Molecular oncology, 12(3), 356-372.

Priya, S. K., Kumar, K., Hiran, K. R., Bindhu, M. R., Nagare, R. P., Vijaykumar, D. K., & Ganesan, T. S. (2017). Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significance. International journal of clinical oncology, 22(1), 107-117.

Jang, J., Kim, M. R., Kim, T. K., Lee, W. R., Kim, J. H., Heo, K., & Lee, S. (2017). CLEC14a-HSP70-1A interaction regulates HSP70-1A-induced angiogenesis. Scientific reports, 7(1), 1-12.

Lee, S., Rho, S. S., Park, H., Park, J. A., Kim, J., Lee, I. K., ... & Kwon, Y. G. (2017). Carbohydrate-binding protein CLEC14A regulates VEGFR-2–and VEGFR-3–dependent signals during angiogenesis and lymphangiogenesis. The Journal of clinical investigation, 127(2), 457-471.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols